CityWizard t1_iyc9f2c wrote on November 30, 2022 at 9:15 AM Reply to comment by Predawnbread in Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding by Relevant_synapse It's too risky, 28% is insignificant for the risk and cost of the drug. You're looking at a $20-30K USD/year and 17% chance for brain hemorrhage. Permalink Parent 3
CityWizard t1_iyc9f2c wrote
Reply to comment by Predawnbread in Alzheimer’s Drug In Development, Lecanemab, May Benefit Some Patients But Carries Risks of Brain Swelling and Bleeding by Relevant_synapse
It's too risky, 28% is insignificant for the risk and cost of the drug. You're looking at a $20-30K USD/year and 17% chance for brain hemorrhage.